Login / Signup

Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation.

Yanhua YangSuxia GuoZiyao HuangChunhua DengLihua ChenGuoxiang ZhouZhengwei JianRuping HeZhichao HuangYongzhao YaoJiongbin LuZhiwen HuaYuli Huang
Published in: Cardiology research and practice (2020)
In HFpEF patients associated with AF, beta-blocker treatment is associated with significantly lower all-cause mortality, but it increased the risk of rehospitalization due to heart failure.
Keyphrases